Hormone-dependent prostate cancer+1
RecruitingStudy on Lutetium (177Lu) Vipivotide Tetraxetan to Delay Recurrence in Adult Men with PSMA-Positive Oligometastatic Prostate Cancer
Study on Lutetium (177Lu) Vipivotide Tetraxetan to Delay Recurrence in Adult Men with PSMA-Positive Oligometastatic Prostate Cancer
- Disease:Hormone-dependent prostate cancerProstate cancer metastatic
- Substances:GozetotidePiflufolastat (18F)+1
Germany- Participants:18–64 years · 65+ years
- Substances:Gozetotide
- Sponsor:Novartis Pharma AG











